A Phase 1, Multi-Center, Open-Label, dose Escalation Study of Thrombosomes in Bleeding thrombocytopenic Patients in Three Cohorts
Principal Investigator (?)
This study evaluates in a dose-escalation manner, the safety, and preliminary impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in thrombocytopenic patients.
BARDA - Biomedical Adv. Research & Development
Available at the following location(s)